Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Gollob

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Biochemical Society Transactions|January 28, 2003
Glycogen storage disease as a unifying mechanism of disease in the PRKAG2 cardiac syndromeM H Gollob
Minerva Cardioangiologica|May 31, 2007
Risk stratification for sudden death in heart failureD Farwell, M H Gollob
European Heart Journal|April 30, 2002
AMP-activated protein kinase and familial Wolff-Parkinson-White syndrome: new perspectives on heart development and arrhythmogenesisM H Gollob, R Roberts
Chest|April 11, 2001
Current status of the implantable cardioverter-defibrillatorM H Gollob, J J Seger
Journal of Cardiovascular Electrophysiology|September 2, 2000
Accessory atrioventricular node with properties of a typical accessory pathway: anatomic-electrophysiologic correlationM H Gollob, S Bharati, C D Swerdlow
The Journal of Rheumatology|November 18, 1998
Postradiation morpheaM H Gollob, J G Dekoven, M J Bell, et al.
Clinical Genetics|November 19, 2013
Evolution of a genetic diagnosisZ Laksman, D Dulay, M H Gollob, et al.
Circulation|December 19, 2001
Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophyM H Gollob, J J Seger, T N Gollob, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 27, 2019
Phospholamban cardiomyopathy: a Canadian perspective on a unique populationC C Cheung, J S Healey, R Hamilton, et al.
Clinical Genetics|August 15, 2012
Detection of genomic deletions of PKP2 in arrhythmogenic right ventricular cardiomyopathyJ D Roberts, J C Herkert, J Rutberg, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biochemical Society Transactions|January 28, 2003
Glycogen storage disease as a unifying mechanism of disease in the PRKAG2 cardiac syndromeM H Gollob
Minerva Cardioangiologica|May 31, 2007
Risk stratification for sudden death in heart failureD Farwell, M H Gollob
European Heart Journal|April 30, 2002
AMP-activated protein kinase and familial Wolff-Parkinson-White syndrome: new perspectives on heart development and arrhythmogenesisM H Gollob, R Roberts
Chest|April 11, 2001
Current status of the implantable cardioverter-defibrillatorM H Gollob, J J Seger
Journal of Cardiovascular Electrophysiology|September 2, 2000
Accessory atrioventricular node with properties of a typical accessory pathway: anatomic-electrophysiologic correlationM H Gollob, S Bharati, C D Swerdlow
The Journal of Rheumatology|November 18, 1998
Postradiation morpheaM H Gollob, J G Dekoven, M J Bell, et al.
Clinical Genetics|November 19, 2013
Evolution of a genetic diagnosisZ Laksman, D Dulay, M H Gollob, et al.
Circulation|December 19, 2001
Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophyM H Gollob, J J Seger, T N Gollob, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 27, 2019
Phospholamban cardiomyopathy: a Canadian perspective on a unique populationC C Cheung, J S Healey, R Hamilton, et al.
Clinical Genetics|August 15, 2012
Detection of genomic deletions of PKP2 in arrhythmogenic right ventricular cardiomyopathyJ D Roberts, J C Herkert, J Rutberg, et al.
Pageof 2